Loading stock data…
Loading stock data…
US$12.00
Get one email when ELOX crosses your level. Checked every 15 minutes during market hours.
▼ -0.02 (-0.17%)down today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
54.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.83
Bearish momentumMACD below its signal line (1.17).
50-day average
8.12
Price aboveShort-term trend reference.
200-day average
2.26
Price aboveLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Eloxx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies for rare disease and other serious conditions. The company’s current work centers on small-molecule genetic therapies, with lead programs aimed at addressing Alport syndrome, a rare kidney disorder, and additional research directed toward cancer and inflammatory diseases. Eloxx Pharmaceuticals applies proprietary technology platforms to discover and advance product candidates designed …
www.eloxxpharma.com3 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-09-01)
3 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-08-01)
3 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-07-01)
3 strong buy · 3 buy · 1 hold · 0 sell · 0 strong sell (7 analysts, 2024-06-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-03-05 | 0.67 | 0.57 | ✗ Miss |
| 2023-11-12 | -1.97 | -1.31 | ✓ Beat |
| 2023-08-10 | -1.54 | -1.96 | ✗ Miss |
| 2023-05-12 | -28.05 | -31.68 | ✗ Miss |
| 2023-04-02 | -2.97 | -2.92 | ✓ Beat |
Companies in the same industry, via Finnhub